Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial
Karan Bami, Sumeet Gandhi, Howard Leong-Poi, Andrew T Yan, Edwin Ho, Mohammed Zahrani, Vinay Garg, Fei Zuo, Hwee Teoh, Adrian Quan, Lawrence A Leiter, Richard E Gilbert, Bernard Zinman, Kevin E Thorpe, Peter Juni, C David Mazer, Subodh Verma, Geraldine Ong, Kim A Connelly
Journal of the American Society of Echocardiography | MOSBY-ELSEVIER | Published : 2020
This trial was supported by an unrestricted investigator-initiated study grant from Boehringer Ingelheim to Drs. Verma and Zinman. The study sponsor was not involved in the study design; data collection, analysis, and interpretation; the writing of this report; or the decision to submit for publication.